Chemoinformaics analysis of (Z)-1-Methyl-2-(undec-6-enyl)quinolin-4(1H)-one
| Molecular Weight | 311.469 | nRot | 9 |
| Heavy Atom Molecular Weight | 282.237 | nRig | 13 |
| Exact Molecular Weight | 311.225 | nRing | 2 |
| Solubility: LogS | -3.235 | nHRing | 1 |
| Solubility: LogP | 5.077 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 29 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 11 |
| nHA | 2 | APOL | 56.309 |
| nHD | 0 | BPOL | 31.671 |
| QED | 0.449 |
| Synth | 2.357 |
| Natural Product Likeliness | 0.86 |
| NR-PPAR-gamma | 0.199 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.08 |
| Pgp-sub | 0.001 |
| HIA | 0.017 |
| CACO-2 | -4.714 |
| MDCK | 0.0000186 |
| BBB | 0.942 |
| PPB | 0.976943 |
| VDSS | 1.302 |
| FU | 0.0083279 |
| CYP1A2-inh | 0.609 |
| CYP1A2-sub | 0.744 |
| CYP2c19-inh | 0.676 |
| CYP2c19-sub | 0.655 |
| CYP2c9-inh | 0.407 |
| CYP2c9-sub | 0.937 |
| CYP2d6-inh | 0.536 |
| CYP2d6-sub | 0.928 |
| CYP3a4-inh | 0.632 |
| CYP3a4-sub | 0.154 |
| CL | 4.632 |
| T12 | 0.59 |
| hERG | 0.314 |
| Ames | 0.716 |
| ROA | 0.138 |
| SkinSen | 0.956 |
| Carcinogencity | 0.304 |
| EI | 0.948 |
| Respiratory | 0.66 |
| NR-Aromatase | 0.115 |
| Antiviral | Yes |
| Prediction | 0.784088 |